default author photo

Jacob S. Bedia

Harvard University - Massachusetts General Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

123

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS

Number of pages: 44 Posted: 22 May 2024
Harvard University - Massachusetts General Hospital, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Queen Mary University of London - Wolfson Institute of Population Health, Imperial College London - AGE Research Unit, University College London, Department of Clinical Biochemistry, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), London School of Economics & Political Science (LSE), Create Health Ltd, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Harvard University - Massachusetts General Hospital
Downloads 123 (584,619)

Abstract:

Loading...

CA-125 Antigen / blood, Carcinoma, Ovarian Epithelial*, Early Detection of Cancer*, Longitudinal Studies, Ovarian Neoplasms* / epidemiology, UKCTOCS, Mass Screening, biomarker, Preclinical history of cancer / preclinical detectable phase / natural history of cancer, Early Diagnosis